Sbi Securities Co., Ltd. Arcellx, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3,596 shares of ACLX stock, worth $223,167. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,596
Previous 4,123
12.78%
Holding current value
$223,167
Previous $316 Million
25.39%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$279 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$247 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$232 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$218 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$188 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.72B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...